- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06293209
Effect of Cool Spray and Cold Packs in Reducing Preoperative Edema and Pain in Ankle Fractures in Ubonratchathani (3-armRCT)
Effect of Cool Spray and Cold Packs in Reducing Preoperative Edema and Pain in Ankle Fractures in Ubonratchathani: 3-arm Parallel-group RCT
The use of evaporative coolants in the management of acute musculoskeletal injury has received increasing attention recently. However, its efficacy compared with conventional cryotherapy in treating injured human subjects remains unclear.
The purpose of this study is to compare the efficacy of evaporative coolants with that of ice packs in the preoperative management of edema and pain in patients with an ankle fracture
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ubonrachathani
-
Multiple Locations, Ubonrachathani, Thailand, 34000
- Department of Orthopedics, Sunpasitthiprasong hospital, Ubonratchathani, Thailand.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Thai male and female individuals
- aged 18 years or older.
- diagnosed by the researcher as having unimalleolar fracture, bimalleolar fracture, or trimalleolar fracture requiring surgery.
- capable of reading and writing in the Thai language.
Exclusion Criteria:
- - Fractures in both ankles.
- Pathologic fractures of the ankle bones.
- Simultaneous fractures of the ankle and leg bones.
- Previous history of ankle fractures.
- Nerve-related disorders causing inflammation around the ankle.
- Peripheral artery disease causing blockages in the leg arteries.
- Infections in the ankle area.
- Cold allergy.
- Inability to read and write in the Thai language
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: The control group (non-cryotherapy group)
Routine preoperative protocol ankle fracture on short leg slab compression with bandage
|
Placebo
Other Names:
|
|
Active Comparator: The cold pack group
The cold pack group consists of patients with ankle fractures who receive cold therapy using ice packs sized 20x20 centimeters.
The ice packs are placed in the freezer compartment for 30 seconds after they have solidified, then applied to the injured ankle for 10 minutes, followed by a 10-minute break.
This process is repeated every 2 hours for a total of 6 times (from 8:00 AM to 6:00 PM).
|
3M cold pack
Other Names:
|
|
Active Comparator: The cold spray
The cold spray group consists of patients with ankle fractures who receive cold therapy using Perskindol cold spray containing Levomenthol.
The spray is applied to the injured ankle 5-6 times, followed by a 10-minute break.
This process is repeated every 2 hours for a total of 6 times (from 8:00 AM to 6:00 PM).
|
Perskindol cold spray
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
swelling
Time Frame: 5 day before surgery
|
Measuring ankle swelling using the figure-of-eight-20 method, which involves measuring the circumference of the ankle and foot using a tape measure placed along the sides of the foot, passing through specific points,3 time and then averaging the measurements obtained in millimeters.
|
5 day before surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pain score
Time Frame: 48 hours
|
Assessing pain levels using the Visual Analog Scale (VAS), a 10-centimeter horizontal line labeled with "no pain at all" at one end and "unbearable pain" at the other.
Participants mark their pain level on the scale from 0 to 10, and pain severity is categorized into 5 levels: no pain (0 points), mild pain (1-3 points), moderate pain (4-6 points), severe pain (7-9 points), and extreme pain (10 points).
|
48 hours
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Sunpasitthiprasong Hospital (Other Identifier: Sunpasitthiprasong Hospital)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ankle Fractures
-
The University of Texas Health Science Center,...AO Trauma North AmericaCompletedDisplaced Ankle FracturesUnited States
-
Hadassah Medical OrganizationCompleted
-
Shaikh Zayed Hospital, LahoreCompletedBimalleolar Ankle FracturePakistan
-
University of ArizonaActive, not recruitingUnstable Ankle Fractures With Syndesmotic DisruptionUnited States
-
Nova Scotia Health AuthorityBauerfeindNot yet recruitingAnkle Fracture | Ankle ArthrodesisCanada
-
Sohag UniversityRecruitingFragility Ankle Fractures and Complex Distal Tibial FracturesEgypt
-
Encore Medical, L.P.RecruitingBimalleolar Ankle FracturesUnited States
-
Utku GürhanNot yet recruitingAnkle Injuries | Ankle FracturesCyprus, Turkey (Türkiye)
-
Brian W. NoehrenRecruiting
-
Cairo UniversityCompleted
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
AkesoNot yet recruitingAtopic DermatitisChina
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of